Navigation Links
Plants defy Mendel's inheritance laws, may prompt textbook changes

igger to make it work in animals," he said.

Once scientists understand more about the mechanism, they then may be able to manipulate it to modify genes already in plants and animals in order to correct mutations that cause diseases and abnormal growth.

Though further research is required to learn how this form of inheritance happens and how it can help improve plants or animals through gene therapy, Pruitt said the discovery has opened an important new line of thinking.

The other researchers involved with this study were Jennifer Victor, a former Purdue graduate student now at Butler University; and Jessica Young, a botany and plant pathology laboratory technician. Lolle, a Purdue research scientist, is currently at the National Science Foundation.


'"/>

Source:Purdue University


Page: 1 2 3

Related biology news :

1. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
2. Plants, animals share molecular growth mechanisms
3. Plants respond similarly to signals from friends, enemies
4. Study: Plants use dual defense system to fight pathogens
5. Plants discriminate between self and non self
6. Prozac for future Plants on Mars
7. Plants reveal a secret and bring researchers nearer a cleaner future
8. Plants have a double line of defence
9. Plants, too, have ways to manage freeloaders
10. Plants give pests sock in the gut
11. Plants used to detect gas leaks, from outer space!

Post Your Comments:
(Date:12/3/2009)...ies can be likened to emptying a museum of its col...dicines into the trash, or replacing every local c...e of species and their habitats may not just make ... also put you at greater risk for catching some na...sity loss,"driven by the replacement of local spec...
(Date:12/3/2009)... CTRC-AACR San Antonio Breast Cancer Symposium con...e and world leaders from industry and academia wit... year, more than 8,500 scientists and other profes...ntion Center in San Antonio from Dec. 9-13, 2009. ...n Association for Cancer Research, the University ...
(Date:12/3/2009)...ty change in warmer water, according to an intrigu...ake some species more aggressive. , Experiments ...s Great Barrier Reef have shown for the first time..., or consistently bold, and that these individual ...ures rise. , A slight lift of just one or two de...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 1LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 2LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 3LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 4LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 5Growth Attracts Additional Investors to Sittercity com 55841 1Growth Attracts Additional Investors to Sittercity com 55841 2iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 1iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 2
...tin has received a six-year contract from the U.S....rt for the AN/UYQ-70 (Q-70) Advanced Display Syste... support at over $13 million a year for the first ...r the next four years, bringing the total potentia...t follows a recently awarded $525.6 million modifi...
...s March 19 during 12 p.m. Advertising Research Fou...e Research (R), a revolutionary media research fir... Advertising Research Foundation (ARF) conference ...identified key themes and styles that comprise imp...which were captured and delivered during the ARF,s...
...niversity of Florida have introduced ,Delicious, a...early, produces high yields, and is disease-resist...d texture with an edible skin, making it well-suit...or wine production. The name ,Delicious, was selec... sampled the fruit., According to Dr. Dennis J. Gr...
Other Biology News:U.S. Navy Awards Lockheed Martin Six-year Contract Worth Up to $72 Million for Advanced Display Systems Support 2Innerscope Research(R) Uses Same-Day Results From Biometric Study to Identify Key Themes, Styles Behind Effective, Engaging Speaker Presentations 2
(Date:12/2/2009)..., LIBREVILLE, Gabon, December 2 /PRNewswire/ -... Everyone,s Problem and Heritage" , Coinc... 2-3 June 2010 the,Gabonese Republic is hosting an... the issue of safeguarding biological resources in...ment and state leaders, ministers,scientific expe...
(Date:12/2/2009)... , CAMBRIDGE, Mass., Dec. 2 Te...aders in technology development and product integr...nounced the December 11th deadline for technology ... its 14th year, TechConnect World, in association ...TI), and the Clean Technology and Sustainable Indu...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte...el oral JAK2 inhibitor, SB1518, at The American So...tion in New Orleans. ,, Data will be presented ...lation trial of SB1518 detailing its safety, toler...) profile in dose levels ranging from 100 to 600 m...
(Date:12/2/2009)..., NANJING, China, Dec. 2 /PRNewswire-Asia/ -...Company") (NYSE: SCR ), a leading pharmaceutical...uring, and marketing of branded,generic and propri...at 105 of,its drugs have been included in China,s ...as issued by China,s Ministry of Human Resources a...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
..., R.I., May 28 Neurotech Pharmaceuticals, Inc. to..., NT-501, demonstrated a strong biologic effect ...ntosa (RP). RP is a slowly developing condition ...mp; cone photoreceptor cells in the retina that ov... eventually leads to blindness. RP is an orphan-de...
...NS, France, May 28 Poxel is a research integrated...ck Serono a division of,Merck KGaA, Germany, follo...est in diabetes research and development. It aims ...iseases (with a primary focus on Type 2,diabetes) ..., before,out-licensing these projects to major pha...
...rovides way of integrating and sustaining positive...28 In today,s uncertain times, increased stress c...rging wellness, growth and behavioral change parad...make healthier lifestyle choices and enjoy increas...llenges. , , The approach, called Reorganizationa...
Other Biology Technology:Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors 2Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors 3Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors 4Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors 5Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management 2Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress 2
Mouse Anti-Human QPRT Monoclonal Antibody, Unconjugated, Clone 5D11 from ABR-Affinity BioReagents
ZOOM IPGRunner Mini-cell from Invitrogen
Rabbit Anti-XTP4 Polyclonal Antibody, Unconjugated from Abcam
Agarose, Type C from Calbiochem
Biology Products: